Your browser doesn't support javascript.
Prescribers' satisfaction with delivering medications for opioid use disorder.
Knudsen, Hannah K; Brown, Randy; Jacobson, Nora; Horst, Julie; Kim, Jee-Seon; Kim, Hanna; Madden, Lynn M; Haram, Eric; Molfenter, Todd.
  • Knudsen HK; Department of Behavioral Science and Center on Drug and Alcohol Research, University of Kentucky, 845 Angliana Ave., Room 204, KY, 40508, Lexington, USA. hannah.knudsen@uky.edu.
  • Brown R; Department of Family Medicine and Community Health, University of Wisconsin-Madison, 1100 Delaplaine Ct, WI, 53715-1896, Madison, USA.
  • Jacobson N; Institute for Clinical and Translational Research, University of Wisconsin-Madison, 4116 Signe Skott Cooper Hall, 701 Highland Ave, WI, 53705, Madison, USA.
  • Horst J; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, 1513 University Ave, WI, 53706, Madison, USA.
  • Kim JS; Department of Educational Psychology, University of Wisconsin-Madison, 1025 West Johnson St, WI, 53706-1706, Madison, USA.
  • Kim H; Department of Educational Psychology, University of Wisconsin-Madison, 1025 West Johnson St, WI, 53706-1706, Madison, USA.
  • Madden LM; Department of Internal Medicine, Yale University, APT Foundation, 1 Long Wharf Drive, Suite 321, CT, 06511, New Haven, USA.
  • Haram E; Haram Consulting, 413 River Road, ME, 04008, Bowdoinham, USA.
  • Molfenter T; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, 1513 University Ave, WI, 53706, Madison, USA.
Subst Abuse Treat Prev Policy ; 16(1): 78, 2021 10 18.
Article in English | MEDLINE | ID: covidwho-1477437
ABSTRACT

BACKGROUND:

Expanding access to medications for opioid use disorder (MOUD), such as buprenorphine and extended release (XR) naltrexone, is critical to addressing the US opioid epidemic, but little is known about prescriber satisfaction with delivering these two types of MOUD. The current study describes the satisfaction of prescribers delivering buprenorphine and XR-naltrexone while examining whether satisfaction is associated with current patient census and organizational environment.

METHODS:

As part of a cluster randomized clinical trial (RCT) focused on expanding access to medication for opioid use disorder, 41 MOUD prescribers in Florida, Ohio, and Wisconsin completed a web-based survey. The survey included measures of prescriber satisfaction with delivering buprenorphine treatment and XR-naltrexone. In addition, the survey measured several prescriber characteristics and their perceptions of the organizational environment.

RESULTS:

Prescribers were generally satisfied with their work in delivering these two types of MOUD. Prescribers reporting a greater number of patients (r = .46, p = .006), those who would recommend the center to others (r = .56, p < .001), and those reporting positive relationships with staff (r = .56, p < .001) reported significantly greater overall satisfaction with delivering buprenorphine treatment. Prescribers who more strongly endorsed feeling overburdened reported lower overall buprenorphine satisfaction (r = -.37, p = .02). None of the prescriber characteristics or perceptions of the organizational environment were significantly associated with overall satisfaction with delivering XR-naltrexone treatment.

CONCLUSIONS:

The generally high levels of satisfaction with both types of MOUD is notable given that prescriber dissatisfaction can lead to turnover and impact intentions to leave the profession. Future research should continue to explore the prescriber characteristics and organizational factors associated with satisfaction in providing different types of MOUD. REGISTRATION ClinicalTrials.gov. NCT02926482. Date of registration September 9, 2016. https//clinicaltrials.gov/ct2/show/NCT02926482 .
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Subst Abuse Treat Prev Policy Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article Affiliation country: S13011-021-00413-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Subst Abuse Treat Prev Policy Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article Affiliation country: S13011-021-00413-7